Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer Ends Claris Supply Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pfizer Ends Claris Supply Pact

Claris compliance issues resolved

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer has terminated its three-year supply agreement with Claris Lifesciences, based in Ahmedabad, India. “Pfizer has terminated its supply agreement and has no current plans to source any products from Claris,” a Pfizer spokesperson said.
 
Pfizer and Claris entered the agreement in 2009 giving Claris access to markets in North America, Europe and Australia. Under the agreement, Pfizer sold 15 generic parenteral products made by Claris under the Pfizer brand name.
 
In 2010, the FDA issued a warning to Claris regarding quality issues and banned the sale of its products in the U.S. until compliance issues were resolved. The FDA lifted the ban earlier this week following a facility inspection in February.
 
In March, Pfizer ended an agreement with Bangalore-based Biocon to sell its insulin products. Pfizer has ongoing supply agreements with Hyderabad-based Aurobindo Pharma and Bangalore-based Strides Arcolab.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters